BBIO Competitors & Alternatives
Compare BridgeBio Pharma Inc with similar stocks in the same industry
Biotechnology
BBIO
Main Stock$81.50
Tradestie Score
52
Market Cap
$10.22B
Revenue Growth
1.2%
Analyst Upside
+33.0%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GMAB
Genmab A/S ADS
|
$33.45
|
$19.56B | 26.9 | 32 | Compare |
|
INCY
Incyte Genomics Inc
|
$127.81
|
$16.93B | 16.4 | 41 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$61.31
|
$15.70B | 32.6 | 42 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$13.16
|
$15.22B | - | 55 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$253.29
|
$12.36B | 19.7 | 51 | Compare |
|
EXEL
Exelixis Inc
|
$54.08
|
$11.09B | 16.9 | 52 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.30
|
$10.76B | - | 48 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$145.13
|
$10.74B | - | 40 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$66.70
|
$10.53B | 188.0 | 42 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$59.74
|
$10.49B | - | 40 | Compare |
More BBIO Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry